Anti-Human RSPO3 Therapeutical Antibody
Recombinant monoclonal antibody expressed in CHO binding to Human RSPO3. Anti-RSPO3 is the first drug in its class to target the R-spondin-LGR pathway, and has shown robust preclinical activity against a number of solid tumor types.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-755CL |
Pricing | Inquiry |
Type | Antibody |
Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |
Target | RSPO3 |
Species Reactivity | Human |